lobbying_activities: 2661803

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2661803	2dbdf66d-c17f-4466-a0e9-461783a082f3	Q2	MEHLMAN CONSULTING, INC.	284950	WEDGEWOOD PHARMACY LLC	2021	second_quarter	ANI	Issues related to animal drug compounding.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2021-07-20T14:57:01.147000-04:00